A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
Public ClinicalTrials.gov record NCT00974974. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to evaluate the safety and efficacy of IPX066 in advanced Parkinson's disease.
Study identification
- NCT ID
- NCT00974974
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 471 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2009 (Type not available)
- Primary completion
- Jan 2011 (Actual)
- Completion
- Mar 2011 (Actual)
- Last update posted
- Aug 11, 2020
2009 – 2011
United States locations
- U.S. sites
- 35
- U.S. states
- 22
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator 17 | Birmingham | Alabama | 35233 | — |
| Investigator 49 | Phoenix | Arizona | 85013 | — |
| Investigator 7 | Little Rock | Arkansas | 72205 | — |
| Investigator 3 | La Jolla | California | 92037 | — |
| Investigator 31 | Sunnyvale | California | 94085 | — |
| Investigator 6 | Torrance | California | 90502 | — |
| Investigator 51 | Aurora | Colorado | 80045 | — |
| Investigator 10 | New Haven | Connecticut | 06510 | — |
| Investigator 64 | Bradenton | Florida | 34205 | — |
| Investigator 61 | Hollywood | Florida | 33021 | — |
| Investigator 5 | Ocala | Florida | 34471 | — |
| Investigator 15 | Port Charlotte | Florida | 33980 | — |
| Investigator 8 | Port Charlotte | Florida | 33980 | — |
| Investigator 4 | St. Petersburg | Florida | 33713 | — |
| Investigator 46 | Augusta | Georgia | 30912 | — |
| Investigator 38 | Boise | Idaho | 83702 | — |
| Investigator 19 | Chicago | Illinois | 60611 | — |
| Investigator 40 | Chicago | Illinois | 60612 | — |
| Investigator 39 | Des Moines | Iowa | 50309 | — |
| Investigator 29 | Kansas City | Kansas | 66160 | — |
| Investigator 1 | Bingham Farms | Michigan | 48025 | — |
| Investigator 21 | New Brunswick | New Jersey | 08901 | — |
| Investigator 25 | Albany | New York | 12208 | — |
| Investigator 8 | Commack | New York | 11725 | — |
| Investigator 12 | New York | New York | 10032 | — |
| Investigator 11 | Durham | North Carolina | 27707 | — |
| Investigator 9 | Raleigh | North Carolina | 27607 | — |
| Investigator 20 | Cincinnati | Ohio | 45219 | — |
| Investigator 42 | Toledo | Ohio | 43614 | — |
| Investigator 60 | Tulsa | Oklahoma | 74137 | — |
| Investigator 14 | Charleston | South Carolina | 29401 | — |
| Investigator 16 | Dallas | Texas | 75390-9016 | — |
| Investigator 13 | Houston | Texas | 77030-2744 | — |
| Investigator 65 | Tacoma | Washington | 98405 | — |
| Investigator 2 | Milwaukee | Wisconsin | 53233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00974974, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2020 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00974974 live on ClinicalTrials.gov.